Cite
The potential of clofarabine in MLL-rearranged infant acute lymphoblastic leukaemia
MLA
Pauline Schneider, et al. “The Potential of Clofarabine in MLL-Rearranged Infant Acute Lymphoblastic Leukaemia.” European Journal of Cancer, vol. 51, no. 14, Jan. 2015, pp. 2008–21. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....08d3a72194e0a2f4e8b68c9e590c7a8f&authtype=sso&custid=ns315887.
APA
Pauline Schneider, Rob Pieters, Ronald W. Stam, & Dominique J. P. M. Stumpel. (2015). The potential of clofarabine in MLL-rearranged infant acute lymphoblastic leukaemia. European Journal of Cancer, 51(14), 2008–2021.
Chicago
Pauline Schneider, Rob Pieters, Ronald W. Stam, and Dominique J. P. M. Stumpel. 2015. “The Potential of Clofarabine in MLL-Rearranged Infant Acute Lymphoblastic Leukaemia.” European Journal of Cancer 51 (14): 2008–21. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....08d3a72194e0a2f4e8b68c9e590c7a8f&authtype=sso&custid=ns315887.